The FDA is pondering approval of Flibanserin yet again. This is the 4th time it's been presented for approval since 2006 when Boehringer Ingelheim initially repackaged their quick-acting antidepressant, flibanserin, as a libido enhancing drug for women. The drug appears to have either minimal or moderately better results than placebo depending on which side of the argument is asked. Even though the results are not very convincing, it looks like the FDA is set to approve it for sale this week.
Below is an excerpt from an article I found in the Washington Post. ?Female Viagra? could get FDA approval this week - The Washington Post The author asks some of the same questions we ask of TAM men who question their wife's low libido.
But it was the last question that I post as food for thought or discussion, whichever.....
And the biggest question: how will the ability to pop a pill change the nature of sex, relationships and intimacy?
Below is an excerpt from an article I found in the Washington Post. ?Female Viagra? could get FDA approval this week - The Washington Post The author asks some of the same questions we ask of TAM men who question their wife's low libido.
"The path for flibanserin, made by Sprout Pharmaceuticals, has been a rocky one, in part because the science of desire is little understood, and in part because there is disagreement on what constitutes "normal" sexual desire. Once a host of other common factors for flagging desire are ruled out - medical conditions, sex-hormone depletion, relationship troubles, some antidepressants, cultural or religious messages, poor body image - questions remain.
Is it mismatched libido with a partner with a higher sex drive, as some contend? Is monogamy just boring? Or is it biology?"
But it was the last question that I post as food for thought or discussion, whichever.....
And the biggest question: how will the ability to pop a pill change the nature of sex, relationships and intimacy?
Put the internet to work for you.
No comments:
Post a Comment